×
0 -0.00478429948211845 -0.00478429948211845 -0.00525396238939438 0.0116539022725422 0.0293758493070907 0.0176029657647051 0.0201078346035104
Stockreport

MHRA grants UK patients early access to Akcea Therapeutics' Volanesorsen for FCS [Seeking Alpha]

Akcea Therapeutics, Inc (AKCA)  More Company Research Source: Seeking Alpha
Last akcea therapeutics, inc earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.akceatx.com/media-investors/press-releases
PDF MHRA grants UK patients early access to Akcea Therapeutics' Volanesorsen for FCSAkcea Therapeutics (NASDAQ:AKCA)announces that volanesorsen has been granted a positive scientific opinion through the Early Access to Medicines Scheme (EAMS) by the UK'sMedicines and Healthcare Products Regulatory Agency (MHRA), for the treatment of familial chylomicronaemia syndrome (FCS), a rare genetic lipid disorder.This decision will enable patients to access volanesorsen before the European Commission makes a formal decision for its use in Europe.FCS is a severe, rare disorder characterised by extremely high levels of triglycerides, daily symptoms such as abdominal pain, and the risk of recurrent, potentially fatal, acute pancreatitis.Click to subscribe to real-time analytics on AKCANow read:Meridian Bio restructures into two business units » [Read more]

IMPACT SNAPSHOT EVENT TIME: AKCA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AKCA alerts
from News Quantified
Opt-in for
AKCA alerts

from News Quantified
Opt-in for
AKCA alerts

from News Quantified